Activation of IL-6R/JAK1/STAT3 signaling induces De Novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation

by Kim, S.M., Kwon, O.-J., Hong, Y.K., Kim, J.H., Solca, F., Ha, S.-J., Soo, R.A., Christensen, J.G., Lee, J.H., Cho, B.C.
Published 2014